Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

201

Full text

168

Free full text

Publication Types

Journal Article

204

Randomized Controlled Trial

123

Research Support, Non-U.S. Gov't

Clinical Trial

Multicenter Study

Comparative Study

Review

Research Support, N.I.H., Extramural

Clinical Trial, Phase III

Systematic Review

Meta-Analysis

Retracted Publication

Case Reports

Controlled Clinical Trial

Observational Study

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Comment

Clinical Trial, Phase IV

Network Meta-Analysis

Editorial

Letter

Research Support, U.S. Gov't, P.H.S.

Consensus Development Conference

Evaluation Study

Publication Year

From

Quick links

Individual year

2024

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Risedronic Acid""[mesh_terms]

207 Results

Searching titles within these results

Novel formulations of oral bisphosphonates in the treatment of osteoporosis.

Nasser Al-Daghri, Friederike Thomasius, Philippe Halbout, Nicholas Fuggle, John A Kanis, Nicola Veronese, Régis Pierre Radermecker, Olivier Bruyère, Mickael Hiligsmann, Maarten de Wit, Salvatore Minisola, Cyrus Cooper, René Rizzoli, Jean-Yves Reginster, Sansin Tuzun, Santiago Palacios, Radmila Matijevic, Stefania Maggi, Andreas Kurth, Jean-Marc Kaufman, Nicholas C Harvey, Andrea Giusti, Bernard Cortet, Etienne Cavalier, Enrique Casado, Jaime Branco, Olivier Bock

Aging clinical and experimental research 2022;34(11):2625-2634

Free Full Text

Abstract

Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites.

F Errassifi, S Sarda, A Barroug, A Legrouri, H Sfihi, C Rey

Journal of colloid and interface science 2014;420():101-11

Free Full Text

Abstract

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment.

Joop P van den Bergh, Kenneth G Saag, Shuang Huang, Arkadi Chines, Klaus Engelke, Roland Chapurlat, Beatriz Oliveri, Eric Lespessailles, Osvaldo D Messina, Bert van Rietbergen, Melissa Sam Bevers, Piet Geusens

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022;37(6):1136-1146

Free Full Text

Abstract

Patients with hip fracture: what can be improved?

Ethel S Siris

Bone 2006;38(2 Suppl 2):S8-12

Full Text

Abstract

Editorial: greater risk, greater benefit--true or false?

Paul D Miller

The Journal of clinical endocrinology and metabolism 2003;88(2):538-41

Full Text

Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients.

Ana Sánchez-Escuredo, David Fuster, Domenico Rubello, Africa Muxí, Ana Ramos, Francisco Campos, Maria Cristina Marzola, Gary J Cook, Andrés Tapias, José-Vicente Torregrosa

Nuclear medicine communications 2016;36(8):815-8

Full Text

Abstract

Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.

Jorge Malouf-Sierra, Umberto Tarantino, Pedro A García-Hernández, Costantino Corradini, Jan J Stepan, Fernando Marin, José Ramón Caeiro, Per Aspenberg, Helmut Petto, Kyriakos Papavasiliou, Frede Frihagen, Søren Overgaard, Lars Borris, Eric Lespessailles

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018;32(5):1040-1051

Free Full Text

Abstract

Osteoporosis management in the new millennium.

Gina S Wei, Jeffrey L Jackson, Christos Hatzigeorgiou, Jeanne K Tofferi

Primary care 2004;30(4):711-41, vi-vii

Full Text

Abstract

Gender differences in osteoporosis treatment: a review of clinical research.

C Crandall

The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 2001;3(8):42-6

Full Text

Abstract

Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.

L Bilek, L Mack, N Waltman, L E Flores, R Blay, K Kupzyk, J Lappe

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2024;35(5):877-891

Full Text

Abstract

The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study.

Jenny Y Y Leung, Andrew Y Y Ho, T P Ip, Gavin Lee, Annie W C Kung

Bone 2005;36(2):358-64

Full Text

Abstract

Current pharmacological treatment for fibrous dysplasia and perspectives for the future.

Roland Chapurlat

Joint bone spine 2005;72(3):196-8

Full Text

Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.

Hélio Rubens de Carvalho Nunes, Fernando Gomes Romeiro, Xingshun Qi, Talles Bazeia Lima, Lívia Alves Amaral Santos

Hepatology international 2022;16(6):1458-1467

Full Text

Abstract

Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature.

R P Kauffman, T H Overton, M Shiflett, J C Jennings

Obstetrical & gynecological survey 2001;56(8):492-504

Full Text

Abstract

The underuse of therapy in the secondary prevention of hip fractures.

Hosam K Kamel, Edmund H Duthie

Drugs & aging 2002;19(1):1-10

Full Text

Abstract

Results: 1 – 15 / 207

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Risedronic Acid""[mesh_terms]

Novel formulations of oral bisphosphonates in the treatment of osteoporosis.

Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites.

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment.

Patients with hip fracture: what can be improved?

Editorial: greater risk, greater benefit--true or false?

Monthly ibandronate versus weekly risedronate treatment for low bone mineral density in stable renal transplant patients.

Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.

Osteoporosis management in the new millennium.

Gender differences in osteoporosis treatment: a review of clinical research.

Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.

The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study.

Current pharmacological treatment for fibrous dysplasia and perspectives for the future.

Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.

Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature.

The underuse of therapy in the secondary prevention of hip fractures.

Results for
""Risedronic Acid""[mesh_terms]